// App-Quantinova.ai

e24039 : Correlation of circulating tumor cell phenotypes based on epithelial-mesenchymal transition with prognosis in first-line chemotherapy of HER2-negative metastatic breast cancer.

Researchers

Presenter

  • Xiuwen Guan

Principal Investigators

  • Fei Ma

  • Chunxiao Li

  • Shiyang Wu

  • Shangying Hu

  • Jiefen Huang

  • Xiaoying Sun

  • Jiayu Wang

  • Yang Luo

  • Ruigang Cai

  • Ying Fan

  • Qiao Li

  • Shanshan Chen

  • Pin Zhang

  • Qing Li

  • Binghe Xu

Medical Centers

  • Cancer Institute/Hospital Chinese Academy of Medical Sciences(CAMS) & Peking Union Medical College(PUMC), Beijing, China

  • Cancer Institute/Hospital Chinese Academy of Medical Sciences(CAMS) & Peking Union Medical College(PUMC), Beijing, China

  • Cancer Institute/Hospital Chinese Academy of Medical Sciences(CAMS) & Peking Union Medical College(PUMC), Beijing, China

  • SurExam Bio-Tech, Guangzhou Technology Innovation Base, Science City, China, Guangzhou, China

  • Cancer Hospital, Beijing, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Circulating tumor cells

  • Human epidermal growth factor receptor 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • III

Study Id's

  • NCT01917279

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved